Trial site

Royal University Hospital

Saskatoon, Saskatchewan S7N 0W8, CanadaNot linked to an institution yet

16running trials
10closed trials

The trials here

What the 27 trials at this site are about, from their registry records.

Conditions: Coronary artery disease5 trials
Stroke4 trials
Ulcerative colitis4 trials
COPD2 trials
Crohn's disease2 trials
Haemophilia2 trials
Asthma1 trial
Atrial fibrillation1 trial
Cervical cancer1 trial
Colorectal cancer1 trial
Depression1 trial
Idiopathic pulmonary fibrosis1 trial
and 5 more
Phase: Phase 313 trials
Phase 23 trials
Phase 2/33 trials
Phase 42 trials
Phase 1/21 trial
Status: Recruiting9 trials
Completed8 trials
Active, not recruiting5 trials
Not yet recruiting2 trials
Terminated2 trials
Suspended1 trial
Lead sponsor: Janssen Research & Development, LLC5 trials
Population Health Research Institute3 trials
University of Calgary3 trials
University of Saskatchewan3 trials
Alfasigma S.p.A.1 trial
and 12 more

Running trials

Recruiting
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT07687056· Phase 3· University of Calgary· Source
Contact: Cassandra Tyson
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648· Maastricht University· Source
Contact: M. Moser, Dr. (principal investigator)
Recruiting
NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy
NCT06403267· Phase 2· NoNO Inc.· Source
Contact: Gary Hunter, MD
Recruiting
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431· Phase 3· University of Calgary· Source
Contact: Cassandra Tyson
Recruiting
Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL
NCT06392776· Ottawa Hospital Research Institute· Source
Contact: Erika Penz, MD
Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
NCT05943535· Phase 3· United Therapeutics· Source
Contact: Veronica Marcoux, Dr. (principal investigator)
Active, not recruiting
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
NCT05701358· Population Health Research Institute· Source
Recruiting
Aggressive Smoking Cessation Trial (ASAP)
NCT05257629· Phase 3· Sir Mortimer B. Davis - Jewish General Hospital· Source
Contact: Rama Mangipudi
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05528510· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471· Phase 2· Janssen Research & Development, LLC· Source
Recruiting
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
NCT04235114· Phase 1/2· University of Saskatchewan· Source
Contact: Ronald Geyer, PhD (sub-investigator)
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source
Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393· Phase 4· Population Health Research Institute· Source
Contact: Michael Prystajecky, MD (principal investigator)
Active, not recruiting
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source
Recruiting
Canadian Network for Autoimmune Liver Disease
NCT03569826· University Health Network, Toronto· Source
Contact: Lawrence Worobetz, MD
Recruiting
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression
NCT03272698· Phase 4· University of Saskatchewan· Source
Contact: Stephen Lee, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Stroke4 recruiting
Asthma1 recruiting
Atrial fibrillation1 recruiting
Colorectal cancer1 recruiting
COPD1 recruiting
Coronary artery disease1 recruiting
Depression1 recruiting
Idiopathic pulmonary fibrosis1 recruiting
Liver and biliary tract cancer1 recruiting
Liver cirrhosis1 recruiting
Lung cancer1 recruiting

Closed trials

Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957· Phase 3· Janssen Research & Development, LLC· Source
Completed
A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors
NCT05053139· Phase 3· Novo Nordisk A/S· Source
Terminated
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
NCT04985968· Phase 3· InDex Pharmaceuticals· Source
Completed
Combination Antiretroviral Therapy (cART) for PBC
NCT03954327· Phase 2· University of Alberta· Source
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
NCT04697628· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source
Terminated
Effect of Sublingual Fentanyl on Breathlessness in COPD
NCT04004117· Phase 2/3· McGill University Health Centre/Research Institute of the McGill University Health Centre· Source
Completed
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
NCT03048825· Phase 3· Population Health Research Institute· Source
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535· Phase 3· Alfasigma S.p.A.· Source
Completed
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
NCT02078427· Baxalta now part of Shire· Source
Completed
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
NCT00673842· Phase 3· University of Calgary· Source

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error